Advancements in Next-Generation Sequencing Technologies
Next-generation sequencing technologies have revolutionized genomic research and enabled exponential growth in genetic sequencing over recent years. Technologies like Illumina's HiSeq and NovaSeq platforms can now sequence an entire human genome in just a few hours for around $1000, enabling applications that were impossible just a decade ago. These dramatic improvements are due to rapid development of sequencing chemistries, flow cells, and other consumables that allow more output and throughput from sequencing instruments. As sequencing demands surge from expanding clinical, agricultural, pharmaceutical and consumer applications, the market for sequencing consumables has grown exponentially.
Growth of Clinical Genomic Testing and Precision Medicine
Widespread clinical adoption of genetic testing is a major driver of Sequencing Consumables demand. Genomic sequencing is now used routinely for cancer screening and treatment, infectious disease diagnosis, carrier screening, prenatal testing, and many other clinical applications. As the cost of whole genome and exome sequencing continues to decline, its use in guiding personalized treatment will only expand further. Biopharma and diagnostic companies are also developing a wide range of genetic tests for various heritable conditions, fueling growth in clinical sequencing. Sequencing is essential for major precision medicine initiatives as well. For example, consortiums like the All of Us Research Program aim to sequence 1 million Americans to advance precision health.
Rise of Agricultural and Food Genomics
Genomic sequencing is transforming agriculture by enabling faster breeding of high-yield climate-resilient crops. Sequencing allows for molecular markers associated with key traits to be identified, shortening the plant breeding cycle from over a decade to just a few years. Companies offering genomic selection and progeny testing services are fueling sequencing demand. Sequencing is also vital in ensuring food safety and authenticity by identifying pathogens, tracing contaminated ingredients, and verifying food labeling claims. Technologies like methylome sequencing further allow tracing food back to its geographic origin. These applications will see significant growth as government regulations tighten.
Surging Demand from Consumer Genetics
Consumer DNA testing kits from companies like AncestryDNA and 23andMe that provide ancestry and health insights based on direct-to-consumer sequencing saw remarkable growth in recent years. Lower sequencing costs now make full genome sequencing accessible to consumers as well. Several startups offer personalized reports on nutrition, fitness and other traits by analyzing customer’s entire genome. Growth in the direct-to-consumer genomics market placed further pressure on consumables manufacturers. While regulatory backlash slowed some testing, COVID-19 has renewed interest in home ancestry, health and trait kits.
Role of Sequencing in Biopharma R&D
Genomic sequencing also underpins modern drug discovery. Sequencing tumor biopsies is crucial for developing more targeted cancer therapies. Genomic analysis of pathogen strains allows creation of vaccines and therapeutics customized for outbreaks. CRISPR and other gene editing tools rely on sequencing to verify on-target modifications. Developing 'biobetter' crops and gene therapies requires extensive functional genomics as well. As biopharma firms ramp up efforts in precision medicine, synthetic biology and genomic regulation, their sequencing needs will multiply significantly. This makes the biotech industry a major long-term consumer of sequencing consumables and services.
Growing Demand for Data Storage and Analysis
As sequencing output scales up rapidly, data storage and analytics present the next bottleneck. A single human genome still generates over 100 gigabytes of data, while microbiome or populations studies produce exponentially more data. Large genomic datasets are essential for developing advanced artificial intelligence and machine learning tools for genomic and clinical applications. However, these state-of-the-art analytics require massively powerful computing and large data center footprints that push cloud and colocation providers to constantly expand infrastructure and bandwidth. This explosive growth in ‘big genomics data’ and computational outsourcing is an adjacent market closely tied to sequencing consumables demand.
Changing Dynamics in the Global Sequencing Market
The sequencing consumables industry is intensely competitive and consolidated among a handful of major manufacturers like Illumina, Thermo Fisher, Qiagen, Agilent and Roche. However, some smaller new entrants from Asia are gaining ground with disruptive chemistries and workflows. For example, companies in China like MGI, BGI and Complete Genomics offer highly automated sequencing platforms and kits that are well suited for large-scale initiatives inprecision health, agriculture and industrial biotech in emerging markets. Collaborations between sequencing giants and emerging market firms will likely reshape competitive landscape and technology access over the long run. geopolitical dynamics will also influence how global sequencing markets evolve to address unmet needs across the world.
Get More Insights On This Topic: Sequencing Consumables
Defib Plus, specialist Automated External Defibrillators UK business’.
We only supply AEDs & their associated consumables.
This was introduced in the year 2005 for commercial use.
Previously, this particular method was known as the massively-parallel sequencing.
The NGS sequencing services known so because it contributes to enabling the sequencing of several DNA strands all at the same time.
Nowadays, these technologies are mostly used in the genetic analysis environment.
In this aspect, Sanger sequencing is best for analyzing the small number of samples and gene targets.
Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition.According to the new market research report Spirometer Market is expected to reach $1,285 million by 2025 from $799 million in 2020, at a CAGR of 11.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659The consumables and accessoriessegment accounted for the largest share of the spirometer market, by product segment, in 2019Based on product, the spirometer products market is segmented into devices, consumables & accessories, and software.The consumables and accessories segment accounted for the largest share of the market in 2019.
The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.Hospitals segment to register the highest growth rate in the Spirometry Market during the forecast period.Based on end user, the Spirometry Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings.
The hospitals segment is expected to account for the highest share in 2019.
Rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced spirometer devices are the factors driving the growth to this market during the forecasted period.spirometer products market Opportunity: Emerging economiesEmerging economies such as India, Brazil, China, and South Africa provide significant opportunities for players in the spirometry devices market.
Of the top 20 most polluted cities in the world, 14 are in India.
The use of spirometers for monitoring lung health is at a very low level in these countries.North America is the largest regional market for spirometer products marketThe global market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).
